Antibacterial Drugs Market to touch US$ 38 Billion By 2023
New York, August 11, 2018: The Antibacterial drugs Market is
segmented based on Class as
Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones/Fluoroquinolones,
Macrolides, Phenicols, Miscellaneous Antibacterials.
The Antibacterial Drugs Market
geographic segmentation covers various regions such as North America, Europe,
Asia Pacific, Latin America, Middle East and Africa. Each geography market is
further segmented to provide market revenue for select countries such as the
U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
The term Antibiotic refers to
antimicrobials which are obtained or derived from the bacteria or molds. Antibacterial drugs have different modes of
action which includes increasing the cell membrane permeability, interfering
with protein synthesis, nucleic acid metabolism, inhibiting cell wall
synthesis. These drugs are used in the treatment as well as prevention of
bacterial infection. These antibiotic
drugs inhibit the growth of or kill the bacteria. The term antibiotic is used to refer to any substance
used against microbes.
The major driving factors of Antibacterial
Drugs Market are as follows:
·
There is a very
high prevalence of infectious diseases.
·
The research and
development activities have increased.
·
Product
differentiation through various methods.
·
Increased
government support.
The restraining factors of Antibacterial drugs Market are as follows:
·
Rise in drug
resistant species.
·
Launch of the
generic drugs.
·
Patent expiry.
This report
provides:
1) An overview of the global Antibacterial Drugs Market and related technologies.
2) Analyses of global market trends and projections of compound annual growth rates (CAGRs) through 2020.
3) Identifications of new market opportunities and targeted promotional plans for Antibacterial Drugs Market.
1) An overview of the global Antibacterial Drugs Market and related technologies.
2) Analyses of global market trends and projections of compound annual growth rates (CAGRs) through 2020.
3) Identifications of new market opportunities and targeted promotional plans for Antibacterial Drugs Market.
4) Discussion of research and
development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for various types of Antibacterial Drugs Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Allergen plc, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Merck & Co., Inc. Novartis AG, Pfizer, Inc., and Sanofi. are provided in the report. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for various types of Antibacterial Drugs Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Allergen plc, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Merck & Co., Inc. Novartis AG, Pfizer, Inc., and Sanofi. are provided in the report. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The
Antibacterial Drugs Market is segmented on the lines of Drug Class and Geography. BY
Drug Class this market is segmented on the basis of Aminoglycosides, B-Lactams,
Tetracyclines, Sulfonamides, Quinolones/Fluoroquinolones, Macrolides, Phenicols
and Miscellaneous Antibacterials. BY Geography this market is segmented on the basis of North America, Asia Pacific, Europe,
Latin America and Africa and Middle East.
Request Sample Report:
Table of Contents
Chapter 1 Introduction
Chapter 2
Executive Summary
Chapter 3 Market
Overview
Chapter 4 Global
Antibacterial Drugs Market Revenue, by Class, 2013 - 2023 (USD Million)
Chapter 5 Global
Antibacterial Drug Pipeline Analysis
5.1 Introduction
5.2 Actoxumab/bezlotoxumab (MK-3415A)
5.2.1
Actoxumab/Bezlotoxumab (MK-3415A) Market Revenue, 2016 – 2022 (USD Million)
5.3 Surotomycin (MK-4261)
5.3.1
Surotomycin (MK-4261) Market Revenue, 2016 – 2022 (USD Million)
5.4 Arikace
5.4.1 Arikace
Market Revenue, 2017 – 2022 (USD Million)
5.5 Cadazolid
5.5.1 Cadazolid
Market Revenue, 2016 – 2022 (USD Million)
5.6 Ciprofloxacin/Fluocinolone
Acetonide
5.6.1
Ciprofloxacin/Fluocinolone Acetonide Market Revenue, 2016 – 2022 (USD Million)
5.7 Zempia (E-101)
5.7.1 Zempia
(E-101) Market Revenue, 2017 – 2022 (USD Million)
5.8 Carbavance (meropenem/RPX7009)
5.8.1
Carbavance Market Revenue, 2017 – 2022 (USD Million)
5.9 Ozenoxacin
5.9.1
Ozenoxacin Market Revenue, 2016 – 2022 (USD Million)
5.10 RHB-105
5.10.1 RHB-105
Market Revenue, 2016 – 2022 (USD Million)
5.11 SPL7013
5.11.1 SPL7013
Market Revenue, 2016 – 2022 (USD Million)
5.12 SYM-1219
5.12.1 SYM-1219
Market Revenue, 2017 – 2022 (USD Million)
5.13 Delafloxacin
5.13.1
Delafloxacin Market Revenue, 2016 – 2022 (USD Million)
5.14 Solithromycin
5.14.1
Solithromycin Market Revenue, 2016 – 2022 (USD Million)
5.15 Eravacycline
5.15.1
Eravacycline Market Revenue, 2016 – 2022 (USD Million)
5.16 Delamanid
5.16.1
Delamanid Market Revenue, 2017 – 2022 (USD Million)
5.17 Omadacycline (PTK-0796)
5.17.1
Omadacycline Market Revenue, 2017 – 2022 (USD Million)
5.18 Plazomycin
5.18.1
Plazomicin Market Revennue, 2017 – 2022 (USD Million)
Chapter 6 Global
Antibacterial Drugs Market Revenue, by Geography, 2013 – 2023 (USD
Million)
Chapter 7
Recommendations
Chapter 8 Company
Profiles
8.1 AstraZeneca
plc
8.2 Allergan plc
(Actavis Plc)
8.3 Bayer AG
8.4 Bristol-Myers
Squibb Company
8.5 Eli Lilly and
Company
8.6
GlaxoSmithKline plc
8.7 Johnson &
Johnson
8.8 Merck &
Co., Inc.
8.9 Novartis AG
8.10 Pfizer, Inc.
8.11 Sanofi
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Comments
Post a Comment